PT  - JOURNAL ARTICLE
AU  - Jonathan P Segal
AU  - Hein Myat Thu Htet
AU  - Jimmy Limdi
AU  - Bu'Hussain Hayee
TI  - How to manage IBD in the ‘elderly’
AID  - 10.1136/flgastro-2019-101218
DP  - 2020 Nov 01
TA  - Frontline Gastroenterology
PG  - 468--477
VI  - 11
IP  - 6
4099  - http://fg.bmj.com/content/11/6/468.short
4100  - http://fg.bmj.com/content/11/6/468.full
SO  - Frontline Gastroenterol2020 Nov 01; 11
AB  - As the incidence of inflammatory bowel disease (IBD) rises and the global population ages, the number of older people living with these conditions will inevitably increase. The challenges posed by comorbid conditions, polypharmacy, the unintended consequences of long-term treatment and the real but often underestimated mismatch between chronological and biological ages underpin management. Significantly, there may be differences in disease characteristics, presentation and management of an older patient with IBD, together with other unique challenges. Importantly, clinical trials often exclude older patients, so treatment decisions are frequently pragmatic, extrapolated from a number of sources of evidence and perhaps primarily dictated by concerns around adverse effects. This review aimed to discuss the epidemiology, clinical features and considerations with management in older patients with IBD.